312 Female sex independently predicts adjuvant immunotherapeutic benefit from CTLA4 immune checkpoint inhibition

• Gary Cohen,
• Omid Hamid,
• Lawrence Flaherty,
• Henry Koon,
• Jeffrey Sosman,
• David Minor,
• Zeynep Eroglu,
• John Kirkwood,
• F Stephen Hodi,
• Donald Lawrence,
• Ni Kang,
• Sandra Lee,
• Laura Hutchins,
• Harriett Kluger,
• Kari Kendra,
• Carrie Lee,
• Mark Albertini,
• Teresa Petrella,
• Howard Striecher,
• Vernon Sondak

Affiliations

Gary Cohen

president and cofounder

Omid Hamid

6Angeles Clinic and Research Institute, Los Angeles, CA, USA

Lawrence Flaherty

Aff2 grid.254444.70000000114567807Karmanos Cancer Center Detroit MI USA

Henry Koon

Aff4 grid.241104.20000000404524020CWRU University Hospitals Cleveland OH USA

Jeffrey Sosman

Aff341 grid.16753.360000000122993507Robert Lurie Comprehensive Cancer Center of Northwestern University Chicago IL USA

David Minor

Aff4 grid.17866.3e0000000098234542California Pacific Center San Francisco CA USA

Zeynep Eroglu

Aff6 grid.468198.a0000000098915233Department of Cutaneous OncologyMoffitt Cancer Center 12902 USF Magnolia Drive 33612 Tampa FL USA

John Kirkwood

16University of Pittsburgh Medical Center, Pittsburgh, PA, USA

F Stephen Hodi

Dana-Farber Cancer Institute, Boston, MA, USA

Donald Lawrence

2Massachusetts General Hospital, Boston, USA

Ni Kang

2Dana Farber Cancer Institute – ECOG-ACRI, Boston, MA, USA

Sandra Lee

3Dana Farber Cancer Institute ECOG-ACRIN, Boston, MA, USA

Laura Hutchins

7University of Arkansas, Little Rock, AR, USA

Harriett Kluger

9Yale University, New Haven, CT, USA

Kari Kendra

13Ohio State University, Columbus, OH, USA

Carrie Lee

15University of North Carolina at Chapel H, Chapel Hill, NC, USA

Mark Albertini

16University of Wisconsin, Madison, WI, USA

Teresa Petrella

18Odette Cancer Center, Toronto, ON, Canada

Howard Striecher

19National Cancer Institute, Rockville, MD, USA

Vernon Sondak

10H. Lee Moffitt Cancer Center, Tampa, FL, USA